METAFORA receives exceptional reimbursement for its new blood test METAglut1

PrevMetafora Biosystems visiting Nashville13 juillet 2017NextMETAFORA receives €3.2 M from H2020 SME Instrument program11 juin 2018

METAFORA receives exceptional reimbursement for its new blood test METAglut1

avril 11, 2018

Metafora biosystems receives exceptional reimbursement for new blood test to help diagnose De Vivo disease

METAglut1 test enables early detection of this rare under-diagnosed disease
A 30-month long study will be carried out on 3,000 patients in 60 centers across France.

> Link to the report (pdf)…

div#stuning-header .dfd-stuning-header-bg-container {background-size: initial;background-position: top center;background-attachment: initial;background-repeat: initial;}#stuning-header div.page-title-inner {min-height: 100px;}